Back
Direxion Daily S&P Biotech Bear 3X ETF Vs. ProShares UltraShort Dow30 Industry Stock Comparison
Sell
40
LABD
Direxion Daily S&P Biotech Bear 3X ETF
Last Price:
5.29
Seasonality Move:
-4.63%
Sell
23
DXD
ProShares UltraShort Dow30
Last Price:
28.07
Seasonality Move:
-10.48%
Sell
40
Direxion Daily S&P Biotech Bear 3X ETF (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P Biotech Bear 3X ETF [LABD] share price is $5.56. The Score for LABD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- LABD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
ProShares UltraShort Dow30 (DXD)
is a Sell
Is ProShares UltraShort Dow30 a Buy, Sell or Hold?
- The current ProShares UltraShort Dow30 [DXD] share price is $28.78. The Score for DXD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- DXD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X ETF's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X ETF share price today is $5.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing buying pressure, which is a positive indicator for future bullish movement.
DXD Stock Price Chart
What is ProShares UltraShort Dow30's stock price today?
-
The ProShares UltraShort Dow30 share price today is $28.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DXD is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 42.76 | Sell |
Chaikin Money Flow: | 17304687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.45 - 6.05) | Sell |
Bollinger Bands (100): | (5.8 - 8.18) | Sell |
DXD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 40.13 | Sell |
Chaikin Money Flow: | 824840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.89 - 29.97) | Sell |
Bollinger Bands (100): | (29.75 - 32.73) | Sell |
LABD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.73 | Sell |
20-day SMA: | 5.7 | Sell |
50-day SMA: | 5.97 | Sell |
200-day SMA: | 8.15 | Sell |
8-day EMA: | 5.66 | Sell |
20-day EMA: | 5.78 | Sell |
50-day EMA: | 6.15 | Sell |
200-day EMA: | 8.96 | Sell |
DXD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.18 | Sell |
20-day SMA: | 29.3 | Sell |
50-day SMA: | 30.1 | Sell |
200-day SMA: | 32.32 | Sell |
8-day EMA: | 29.05 | Sell |
20-day EMA: | 29.42 | Sell |
50-day EMA: | 30.14 | Sell |
200-day EMA: | 32.91 | Sell |
Direxion Daily S&P Biotech Bear 3X ETF Earnings Growth & LABD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Dow30 Earnings Growth & DXD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily S&P Biotech Bear 3X ETF Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares UltraShort Dow30 Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |